Management of neonatal aortic arch thrombosis with low-molecular weight heparin: A case series

22Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Aortic arch thrombosis (AAT) is a potentially life threatening condition in neonates. We report 3 neonates with AAT and complete occlusion of a unilateral internal carotid artery with multiple cerebral infarcts. Multidisciplinary input led to deferral of thrombolytic therapy and surgical thrombectomy owing to the potential risk of hemorrhage within the infarcts. All the neonates were treated with low-molecular weight heparin treatment alone without any complications. Thrombus resolution was complete in 2 neonates, whereas it was near complete in one neonate. All the infants showed normal growth and development during follow-up. The rewarding outcome in these cases suggests that treatment with low-molecular weight heparin could be considered an option to treat AAT in selected patients. © 2009 by Lippincott Williams & Wilkins.

Cite

CITATION STYLE

APA

Sharathkumar, A. A., Lamear, N., Pipe, S., Parikh, S., Russell, M., Simon, A., & Shapiro, A. (2009). Management of neonatal aortic arch thrombosis with low-molecular weight heparin: A case series. Journal of Pediatric Hematology/Oncology, 31(7), 516–521. https://doi.org/10.1097/MPH.0b013e3181a6e030

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free